The federal patent office rejected separate challenges from JinkoSolar, Canadian Solar and Mundra Solar to invalidate intellectual property that First Solar claims is fundamental to the manufacturing ...

First Solar said on Tuesday the United States Patent and Trademark Office director denied three separate third-party ...

Barnes & Thornburg attorneys Lauren Baker and John W. Cox examine the practical uses, benefits, and challenges of using ...

A new study published in the Strategic Management Journal sheds light on how multinational firms make strategic decisions ...

This case[1] involves an appeal from Regeneron Pharmaceuticals, Inc.’s (Regeneron) efforts to prevent defendants from marketing biosimilar versions of EYLEA®, a drug used to treat eye diseases, by ...

"One key issue that has arisen in funded patent litigation is transparency—in other words, to what extent must funder involvement in a patent infringement action be revealed? This article tackles this ...

AR glasses maker XREAL is taking its competitor VITURE to court over a patent dispute, claiming that it’s selling and/or ...

Apple has been accused of infringing on a European patent covering gaze correction, the feature used to correct a user's eye ...

BeOne Medicines and AbbVie’s Pharmacyclics have decided to voluntarily dismiss the patent lawsuit the Big Pharma firm brought against its competitor over their BTK inhibitors. The patent covers a ...

According to Canadian Solar, the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) has ruled in its favor, stating that “all claims asserted by Maxeon ...

This week on IPWatchdog Unleashed, we enter the patent litigation world for a conversation about gaming patent litigation. For too long, popular sentiment has been that patent owners are bad actors ...